We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Featured Articles

Multichannel pipette dispensing samples into a 96-well plate during high-throughput screening.

How High-Throughput Screening Is Transforming Modern Drug Discovery

This article explores how advances in automation, 3D cell models and AI are transforming high-throughput screening, driving faster and more predictive drug discovery.

Digital interface with icons for policies, regulations and law highlighting data compliance concepts.

Data Compliance: Can AI Help Users Navigate New Technologies and Regulations?

AI tools are reshaping how labs handle compliance, from automating audit trails to improving data reuse and accuracy. In this article, we examine how the rise of AI is transforming compliance and how users can stay informed.

3D illustration of an adeno-associated virus (AAV), commonly used in gene therapy research.

Techniques and Advancements in Recombinant Adeno-Associated Virus Purification for Gene Therapies

This article examines key innovations driving scalable, high-yield purification of recombinant AAVs and how they’re helping overcome manufacturing bottlenecks in gene therapy.

Latest Articles

Blue antibodies floating on a dark background, illustrating antibody screening.

Antibody Screening Innovations: Affinity and Beyond

This article explores how innovative screening methods and AI are advancing therapeutic antibody discovery by improving throughput, reducing bias and enabling deeper insights.

Illustration of a targeted cancer cell surrounded by immune cells, symbolizing cancer drug discovery.

Cancer Drug Discovery: Reaching for the High-Hanging Fruit

Researchers are developing new strategies to drug the undruggable in cancer, including targeting intracellular KRAS with radio-labeled antibodies and using AI and quantum computing to overcome drug resistance.

Business man in suit holding money in a fan shape.

Why the Current Research Funding Model Needs an Overhaul

For this article, Technology Networks asked a diverse group of academics and industry leaders: How should research funding change to better support innovation? Here’s how current models help – or hinder – their work.

A scientist working on a bioreactor before performing downstream processing of the biopharmaceutical product.

Purification Technologies Advancing Downstream Processing of Biopharmaceuticals

Explore cutting-edge technologies and workflows advancing downstream processing in biopharma, driving purification efficiency and innovation in new therapies.

A person in a white lab coat "holding" an oversized red and white pill.

Resurrecting Ancient Antibiotics With AI

Presenting at Technology Networks’ Innovations in Disease Modeling 2025 event, Dr. de la Fuente outlined how his lab is using artificial intelligence to reimagine antibiotic discovery – by turning to the human proteome and ancient genomes.

Drug capsules floating on a dark background with text about European pharma and US uncertainty overlaid.

What Could Lower US Drug Prices Cost the Rest of the World?

What happens if the US ties drug prices to other nations? Discover how the most-favored-nation policy could shake the global pharmaceutical industry.

A gloved hand holds a white capsule between thumb and finger. Test tubes and petri dishes visible.

Automation in Drug Discovery Is Accelerating Workflows

Discover how Agilent's AssayMAP Bravo and RapidFire systems accelerate drug discovery with automation and rapid, reliable mass spectrometry.

A person standing in a minimalist, modern space, gazing upward, symbolizing curiosity and the future of science.

What Skills Do the Next Generation of Scientists Need?

Nine scientists from academia and industry offer their take on the crucial skills tomorrow’s scientists will need to thrive in an evolving research landscape, from AI to digital lab fluency.

Rainbow heart representing LGBTQ+ held by gloved hands.

Building a More Inclusive Future in Biotech

Technology Networks recently had the pleasure of interviewing Dr. Tyler Brown, founder, president and chair of OUTbio San Diego, to learn more about the organization’s origins, rapid growth and mission to create lasting impact.

Person holding a GLP-1 injection pen used for managing type 2 diabetes and weight loss.

Beyond GLP-1s: Rethinking Obesity Treatment for the Long Term

GLP-1 drugs like semaglutide and tirzepatide show promise in treating obesity, with benefits including weight loss and improved metabolic health. However, concerns about long-term safety, cost, and accessibility remain.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter